glutamine has been researched along with thromboplastin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Foster, DC; Kazama, Y; Kisiel, W | 1 |
| Grindflek, A; Kavlie, A; Orning, L; Prydz, H; Stormorken, H | 1 |
| Chang, SC; Chang, YJ; Hamaguchi, N; Lin, SW; Ruf, W; Shen, MC | 1 |
| Kane, WH; Kim, SW; Lentz, BR; Ortel, TL; Quinn-Allen, MA; Worfolk, L; Yoo, L; Zhai, X | 1 |
| Cook, BC; Kurumbail, RG; Miletich, JP; Porche-Sorbet, R; Rudolph, AE | 1 |
| Berti de Marinis, G; Bonamigo, E; Girolami, A; Sartori, R; Vettore, S | 1 |
| Hirbawi, J; Kalafatis, M; Wiencek, JR; Yee, VC | 1 |
7 other study(ies) available for glutamine and thromboplastin
| Article | Year |
|---|---|
Evidence that an Arg79-->Gln substitution in human factor VII is not associated with a reduction in coagulant activity.
Topics: Animals; Arginine; Cells, Cultured; Cricetinae; Enzyme Activation; Factor VII; Factor X; Fibroblasts; Glutamine; Hemostasis; Humans; Kidney; Mesocricetus; Mutagenesis, Site-Directed; Oligopeptides; Recombinant Fusion Proteins; Thromboplastin | 1992 |
Characterization of a factor VII molecule carrying a mutation in the second epidermal growth factor-like domain.
Topics: Adolescent; Adult; Alleles; Amino Acid Sequence; Animals; Binding Sites; Blood Coagulation Tests; Child; Child, Preschool; CHO Cells; Codon; Cricetinae; DNA Mutational Analysis; Enzyme Activation; Factor VII; Factor VII Deficiency; Factor X; Female; Genotype; Glutamine; Humans; Male; Middle Aged; Models, Molecular; Molecular Sequence Data; Norway; Point Mutation; Protein Structure, Tertiary; Recombinant Proteins; Thromboplastin; Transfection | 1998 |
Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.
Topics: Amino Acid Substitution; Anticoagulants; Antithrombin III; Blood Coagulation Tests; Catalysis; Cell Line; Chromogenic Compounds; Factor VII; Factor X; Factor Xa; Gene Expression Regulation; Glutamine; Humans; Lipoproteins; Macromolecular Substances; Mutagenesis, Site-Directed; Protein Binding; Protein Engineering; Recombinant Proteins; Substrate Specificity; Thromboplastin; Transfection | 1999 |
Partial glycosylation at asparagine-2181 of the second C-type domain of human factor V modulates assembly of the prothrombinase complex.
Topics: Animals; Asparagine; Cell Membrane; COS Cells; Factor V; Factor Va; Glutamine; Glycoside Hydrolases; Glycosylation; Humans; Mutagenesis, Site-Directed; Peptide Fragments; Protein Binding; Protein Structure, Tertiary; Recombinant Proteins; Thromboplastin; Transfection | 1999 |
Directed glycosylation of human coagulation factor X at residue 333. Insight into factor Va-dependent prothrombin catalysis.
Topics: Amino Acid Substitution; Asparagine; Catalysis; Factor IXa; Factor Va; Factor VIIa; Factor X; Factor Xa; Glutamine; Glycosylation; Humans; Kinetics; Models, Molecular; Mutagenesis, Site-Directed; Protein Structure, Secondary; Prothrombin; Recombinant Proteins; Substrate Specificity; Thromboplastin | 2000 |
Ox brain versus rabbit brain thromboplastin assays are the best tool for a preliminary diagnosis of the Arg304Gln factor VII defect (FVII Padua).
Topics: Amino Acid Substitution; Animals; Arginine; Brain Chemistry; Cattle; Factor VII; Glutamine; Homozygote; Humans; Rabbits; Thromboplastin | 2010 |
The Dual Regulatory Role of Amino Acids Leu480 and Gln481 of Prothrombin.
Topics: Amino Acid Motifs; Amino Acid Sequence; Factor Va; Factor Xa; Glutamine; Humans; Leucine; Molecular Sequence Data; Protein C; Protein Processing, Post-Translational; Prothrombin; Thromboplastin | 2016 |